Form 4 for RMTI ROCKWELL MEDICAL, INC.
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-14 · accession 0001104659-24-035044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-15 | 2024-03-14 | RMTI | Strobeck Mark | Pres, CEO, Dir | A - Grant | $0.00 | +100.0K | 155.5K | +180% | $0 |
| D | 2024-03-15 | 2024-03-14 | RMTI | Strobeck Mark | Pres, CEO, Dir | A - Grant | $0.00 | +141.6K | 141.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | A | A | 100,000 | $0.00 | 155,465 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-03-14 | A | A | 141,560 | $0.00 | 141,560 | D | $1.39 · — to 2034-03-14 | 141,560 Common Stock | (F2) Stock options vest 25% on the first anniversary of March 14, 2024, with the remainder vesting in equal monthly installments through March 14, 2028, subject to the Reporting Person's continued service to the Issuer. |